News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
750,054 Results
Type
Article (47031)
Company Profile (272)
Press Release (702736)
Multimedia
Podcasts (102)
Webinars (24)
Section
Business (210376)
Career Advice (2185)
Deals (36338)
Drug Delivery (133)
Drug Development (83477)
Employer Resources (178)
FDA (16973)
Job Trends (15294)
News (355987)
Policy (33847)
Tag
2027 BioCapital Elite (1)
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2751)
Accelerated approval (42)
Adcomms (32)
Allergies (162)
Alliances (51048)
ALS (195)
Alzheimer's disease (1805)
Antibody-drug conjugate (ADC) (380)
Approvals (17272)
Artificial intelligence (612)
Autoimmune disease (231)
Automation (50)
Bankruptcy (370)
Best Places to Work (11849)
BIOSECURE Act (21)
Biosimilars (211)
Biotechnology (177)
Bladder cancer (181)
Brain cancer (65)
Breast cancer (702)
Cancer (5436)
Cardiovascular disease (464)
Career advice (1856)
Career pathing (42)
CAR-T (305)
CDC (55)
Celiac Disease (2)
Cell therapy (814)
Cervical cancer (42)
Clinical research (71687)
Collaboration (1936)
Company closure (5)
Compensation (1272)
Complete response letters (76)
COVID-19 (2818)
CRISPR (99)
C-suite (995)
Cystic fibrosis (150)
Data (7110)
Decentralized trials (3)
Denatured (30)
Depression (155)
Dermatology (58)
Diabetes (567)
Diagnostics (7039)
Digital health (53)
Diversity (12)
Diversity, equity & inclusion (46)
Drug discovery (300)
Drug pricing (211)
Drug shortages (34)
Duchenne muscular dystrophy (267)
Earnings (93187)
Editorial (63)
Employer branding (22)
Employer resources (156)
Events (121826)
Executive appointments (1050)
FDA (20423)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (29)
Funding (1643)
Gene editing (211)
Generative AI (53)
Gene therapy (667)
GLP-1 (1079)
Government (4886)
Grass and pollen (7)
Guidances (398)
Healthcare (19456)
HIV (75)
Huntington's disease (53)
IgA nephropathy (96)
Immunology and inflammation (295)
Immuno-oncology (84)
Indications (157)
Infectious disease (3140)
Inflammatory bowel disease (213)
Inflation Reduction Act (14)
Influenza (129)
Intellectual property (275)
Interviews (342)
IPO (16918)
IRA (54)
Job creations (3767)
Job search strategy (1553)
JPM (59)
Kidney cancer (19)
Labor market (93)
Layoffs (586)
Leadership (38)
Legal (8243)
Liver cancer (102)
Longevity (28)
Lung cancer (737)
Lymphoma (406)
Machine learning (52)
Management (61)
Manufacturing (944)
MASH (184)
Medical device (14274)
Medtech (14354)
Mergers & acquisitions (20580)
Metabolic disorders (1471)
mRNA (184)
Multiple sclerosis (176)
NASH (18)
Neurodegenerative disease (399)
Neuropsychiatric disorders (100)
Neuroscience (3229)
Neurotech (1)
NextGen: Class of 2026 (6692)
Non-profit (4660)
Now hiring (73)
Obesity (706)
Opinion (298)
Ovarian cancer (187)
Pain (233)
Pancreatic cancer (260)
Parkinson's disease (350)
Partnered (34)
Patents (564)
Patient recruitment (597)
Peanut (60)
People (60860)
Pharmaceutical (62)
Pharmacy benefit managers (32)
Phase 1 (22293)
Phase 2 (31508)
Phase 3 (23572)
Pipeline (7163)
Policy (321)
Postmarket research (2697)
Preclinical (9554)
Press Release (64)
Prostate cancer (283)
Psychedelics (51)
Radiopharmaceuticals (310)
Rare diseases (1019)
Real estate (6162)
Recruiting (71)
Regulatory (25720)
Reports (54)
Research institute (2524)
Resumes & cover letters (369)
Rett syndrome (32)
RNA editing (17)
RSV (90)
Schizophrenia (168)
Series A (270)
Series B (202)
Service/supplier (11)
Sickle cell disease (107)
Special edition (23)
Spinal muscular atrophy (169)
Sponsored (46)
Startups (3737)
State (2)
Stomach cancer (18)
Supply chain (121)
Tariffs (89)
The Weekly (70)
Vaccines (1114)
Venture capital (102)
Weight loss (459)
Women's health (112)
Worklife (20)
Date
Last 7 days (648)
Last 30 days (2462)
Last 365 days (30421)
2026 (8125)
2025 (30721)
2024 (35820)
2023 (40808)
2022 (52036)
2021 (56618)
2020 (55090)
2019 (47845)
2018 (36098)
2017 (33195)
2016 (32722)
2015 (38838)
2014 (32526)
2013 (27678)
2012 (29952)
2011 (30574)
2010 (28718)
Location
Africa (803)
Alabama (90)
Alaska (7)
Arizona (338)
Arkansas (13)
Asia (41729)
Australia (6869)
California (12336)
Canada (3522)
China (1262)
Colorado (525)
Connecticut (525)
Delaware (368)
Europe (91876)
Florida (1855)
Georgia (402)
Hawaii (3)
Idaho (63)
Illinois (971)
India (83)
Indiana (564)
Iowa (22)
Japan (493)
Kansas (131)
Kentucky (44)
Louisiana (39)
Maine (85)
Maryland (1494)
Massachusetts (8853)
Michigan (356)
Minnesota (681)
Mississippi (6)
Missouri (147)
Montana (33)
Nebraska (29)
Nevada (135)
New Hampshire (84)
New Jersey (3283)
New Mexico (29)
New York (3260)
North Carolina (1598)
North Dakota (8)
Northern California (6082)
Ohio (370)
Oklahoma (23)
Oregon (42)
Pennsylvania (2488)
Puerto Rico (26)
Rhode Island (50)
South America (1184)
South Carolina (76)
South Dakota (1)
Southern California (4854)
Tennessee (202)
Texas (1948)
United States (43830)
Utah (371)
Vermont (1)
Virginia (293)
Washington D.C. (82)
Washington State (988)
West Virginia (4)
Wisconsin (127)
Wyoming (2)
750,054 Results for "block imaging international inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Liminatus Pharma Announces Planned Phase 1 Clinical Trial of IBA101, a Next-Generation CD47 Blocking Antibody
March 17, 2026
·
3 min read
Press Releases
TLX250-CDx (Zircaix) Included in Leading International Guidelines for Renal Imaging
October 23, 2025
·
9 min read
Press Releases
Polyrizon Announces New Pre-Clinical Results: PL-14 Demonstrates Significant Allergen-Blocking Performance Compared to a Standard Comparator
January 5, 2026
·
5 min read
Press Releases
Vivos Inc. Diversifies Manufacturing Base with Planned U.S. and International Production Sites
February 17, 2026
·
2 min read
Press Releases
Drug Prevents Congenital Heart Block Recurrence in a High-Risk Pregnancy
October 22, 2025
·
4 min read
Legal
Delaware Court Denies Pfizer’s Bid To Block Novo-Metsera Deal
The court’s decision allows Metsera to walk away from its previous acquisition agreement with Pfizer in favor of Novo Nordisk’s higher bid.
November 6, 2025
·
2 min read
·
Tristan Manalac
Press Releases
QT Imaging Receives UAE Regulatory Clearance
March 24, 2026
·
6 min read
Press Releases
Philips agrees to acquire SpectraWAVE Inc., advancing next-generation coronary intravascular imaging and physiological assessment with AI
December 15, 2025
·
8 min read
Press Releases
Polyrizon Demonstrates Reversible Broad-Spectrum Viral Blocking by Its Intranasal Barrier-Forming Formulation
November 7, 2025
·
5 min read
IPO
‘Valentine’s Day Massacre’: Deerfield Claims Alcon is Blocking Aurion’s IPO
Deerfield Management claims that Alcon Research is seeking a discounted takeover of Aurion Biotech while blocking the startup’s efforts to go public.
February 25, 2025
·
2 min read
·
Tristan Manalac
1 of 75,006
Next
